FDA Import Refusal SCS-8705292-7/11/1A — Cires Pharmaceutical Inc.
The FDA refused shipment SCS-8705292-7/11/1A from Cires Pharmaceutical Inc. (South Korea) on Jul 28, 2023. The refused product falls under Drugs and Biologics — LIDOCAINE. Cited charges: 118,3280,75
Refusal details
- Date
- Jul 28, 2023
- Country
- South Korea
- Product Category
- Drugs and Biologics
- Product Code
- 60QBJ07 LIDOCAINE
- Charges
- 118,3280,75